Clinical Trials Logo
  1. Home
  2. Liver Cancer
  3. NCT04825470
  4. Details
NCT04825470 Clinical Trial

Liver Transplantation for Unresectable GIST Liver Metastases

Liver Cancer Clinical Trial

— TRANSGIST  

Official title:
Liver Transplantation in Patients With Unresectable GastroIntestinal Stromal Tumors (GIST) Liver Metastases

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04825470
Other study ID # TRANSGIST
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2022
Est. completion date December 2025

Study information
Verified date February 2022
Source Hospital Universitario Virgen de la Arrixaca
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Liver Transplantation for Unresectable GIST Liver Metastases

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 50
Est. completion date December 2025
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - GIST diagnosis (c-Kit, CD34, DOG-1) - Imatinib-sensitive mutation - Non-resectable liver metastases - Abscence of extrahepatic disease - Period greater than two years between primary tumor and metastases diagnosis

Study Design

Related Conditions & MeSH terms

  • Carcinoma, Hepatocellular
  • Colorectal Neoplasms
  • Disease
  • Gastrointestinal Stromal Tumor (GIST) of the Gastrointestinal Tract
  • Gastrointestinal Stromal Tumor by AJCC V8 Stage
  • Gastrointestinal Stromal Tumor of Duodenum
  • Gastrointestinal Stromal Tumor of Esophagus (Disorder)
  • Gastrointestinal Stromal Tumor of Large Intestine (Disorder)
  • Gastrointestinal Stromal Tumor of Other Sites
  • Gastrointestinal Stromal Tumor of Rectum
  • Gastrointestinal Stromal Tumor of Small Intestine (Disorder)
  • Gastrointestinal Stromal Tumor of Stomach
  • Gastrointestinal Stromal Tumor, Malignant
  • Gastrointestinal Stromal Tumor, Unspecified Site
  • Gastrointestinal Stromal Tumors
  • GIST
  • GIST, Malignant
  • Liver Cancer
  • Liver Carcinoma
  • Liver Diseases
  • Liver Mass
  • Liver Metastases
  • Liver Neoplasms
  • Liver Transplant Disorder
  • Liver Transplant; Complications
  • Liver Transplantation
  • Metastases
  • Metastases to Liver
  • Metastasis
  • Metastatic Liver Cancer
  • Neoplasm Metastasis
  • Neoplasms
  • Neoplasms, Second Primary
  • Transplant Oncology

Intervention

Procedure:
• Liver Transplantation
Liver Transplantation

Locations
Country Name City State
Spain Felipe Alconchel Murcia

Sponsors (1)
Lead Sponsor Collaborator
Hospital Universitario Virgen de la Arrixaca

Country where clinical trial is conducted

Spain, 

References & Publications (1)

Fernández JÁ, Alconchel F, Gómez B, Martínez J, Ramírez P. Unresectable GIST liver metastases and liver transplantation: A review and theoretical basis for a new indication. Int J Surg. 2021 Oct;94:106126. doi: 10.1016/j.ijsu.2021.106126. Epub 2021 Sep 27. Review. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Overall Survival Survival Through study completion, an average of 2 years
Primary Graft Survival Liver graft Survival Through study completion, an average of 2 years
Secondary Relapse free survival Through study completion, an average of 2 years
Secondary Disease free survival Through study completion, an average of 2 years
See also
  Status Clinical Trial Phase
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Terminated NCT00788125 - Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Phase 1/Phase 2
Completed NCT03756597 - PAN-study: Pan-Cancer Early Detection Study (PAN)
Recruiting NCT05160740 - Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer N/A
Completed NCT01906021 - Study of New Software Used During Ablations N/A
Terminated NCT04589884 - Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment
Recruiting NCT05953337 - Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) N/A
Enrolling by invitation NCT04466124 - Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam Therapy
Not yet recruiting NCT04053231 - Hepatocarcinoma Recurrence on the Liver Study - Part2
Active, not recruiting NCT02869217 - Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors Phase 1
Completed NCT03059238 - Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure Phase 3
Recruiting NCT02632188 - Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma Phase 1/Phase 2
Recruiting NCT01388101 - Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor) N/A
Completed NCT00980239 - HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver Phase 1
Terminated NCT00903396 - Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer Phase 2
Completed NCT01042041 - Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer Phase 1
Completed NCT00790569 - Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking N/A
Completed NCT00543777 - Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease Phase 1/Phase 2
Terminated NCT00896467 - Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy N/A